Market Movers rounded up the best reactions from investors and analysts on Johnson & Johnson 's latest quarterly results. The experts, including Jim Cramer , discussed the health-care giant as its shares fell 2.8% on Tuesday.
Johnson & Johnson posted first-quarter adjusted earnings and revenue that beat expectations , but dialed back its sales guidance for its pharmaceutical business. Johnson & Johnson is currently held in Jim Cramer's Charitable Trust portfolio.
When is rhe split/spin off?
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreShares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell. JnJ tanking…probably because Jim Cramer opened his mouth. Whatever stock he mentions, tanks📉📉📉.
La source: CNBC - 🏆 12. / 72 Lire la suite »
Johnson & Johnson beats on earnings and revenue, raises full-year guidanceEARNINGS: J&J reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year forecast. CFO Joseph Wolk joins us to discuss. Nothing on Liability on talc? Texas 2 step shouldn’t be allowed So they should stop using shell game bankruptcy strategies to avoid their legal responsibilities to women their product harmed.
La source: CNBC - 🏆 12. / 72 Lire la suite »